| Title |
Snake venom components and their applications in biomedicine
|
|---|---|
| Published in |
Cellular and Molecular Life Sciences, November 2006
|
| DOI | 10.1007/s00018-006-6315-0 |
| Pubmed ID | |
| Authors |
D. C. I. Koh, A. Armugam, K. Jeyaseelan |
| Abstract |
Snake envenomation is a socio-medical problem of considerable magnitude. About 2.5 million people are bitten by snakes annually, more than 100,000 fatally. However, although bites can be deadly, snake venom is a natural biological resource that contains several components of potential therapeutic value. Venom has been used in the treatment of a variety of pathophysiological conditions in Ayurveda, homeopathy and folk medicine. With the advent of biotechnology, the efficacy of such treatments has been substantiated by purifying components of venom and delineating their therapeutic properties. This review will focus on certain snake venom components and their applications in health and disease. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 480 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 5 | 1% |
| Brazil | 3 | <1% |
| United Kingdom | 2 | <1% |
| Netherlands | 1 | <1% |
| Australia | 1 | <1% |
| Austria | 1 | <1% |
| Turkey | 1 | <1% |
| Sudan | 1 | <1% |
| India | 1 | <1% |
| Other | 2 | <1% |
| Unknown | 462 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 115 | 24% |
| Student > Ph. D. Student | 80 | 17% |
| Student > Master | 59 | 12% |
| Researcher | 37 | 8% |
| Student > Doctoral Student | 25 | 5% |
| Other | 75 | 16% |
| Unknown | 89 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 151 | 31% |
| Biochemistry, Genetics and Molecular Biology | 86 | 18% |
| Chemistry | 32 | 7% |
| Medicine and Dentistry | 30 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 26 | 5% |
| Other | 51 | 11% |
| Unknown | 104 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 January 2016.
All research outputs
#2,415,851
of 23,794,258 outputs
Outputs from Cellular and Molecular Life Sciences
#318
of 4,151 outputs
Outputs of similar age
#4,856
of 69,633 outputs
Outputs of similar age from Cellular and Molecular Life Sciences
#4
of 35 outputs
Altmetric has tracked 23,794,258 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,151 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 69,633 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.